Episode

Ivermectin or Molnupiravir

Podcast
Dr. John Campbell
Published
Sep 12, 2026
Duration seconds
2187
Processing state
not_requested
Canonical source
https://traffic.megaphone.fm/VG4574951607.mp3
Audio
https://traffic.megaphone.fm/VG4574951607.mp3
JSON
/v1/public/podcasts/dr-john-campbell-7851784/episodes/ivermectin-or-molnupiravir
Markdown
/podcast/dr-john-campbell-7851784/ivermectin-or-molnupiravir.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/dr-john-campbell-7851784/episodes/ivermectin-or-molnupiravir/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/dr-john-campbell-7851784/ivermectin-or-molnupiravir.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Link to featured video https://www.youtube.com/watch?v=ctwX1cz_-dw&t=323s Link to Wefwafwa’s channel https://www.youtube.com/channel/UCzsLklGgOttU3Se-WGLp7ow (he needs more subscribers) Link to support Wefwafwa’s work in Africa patreon:https://www.patreon.com/awmedicalvideos Drugs Shown to Inhibit SARS-CoV-2 in COVID-19 Disease: Comparative Basic and Clinical Pharmacology of Molnupiravir and Ivermectin https://austinpublishinggroup.com/pharmacology-therapeutics/fulltext/ajpt-v9-id1149.pdf https://www.linkedin.com/in/leslie-adesuyi-ajayi-md-phd-fbpharmacols-fwacp-69154a38/ There are still many nations where vaccines are not yet widely available, There is a gradual shift in focus, to antiviral drugs, Adjunctive chemoprophylaxis Active treatment of new SARS-CoV-2 infections Post -vaccination breakthrough COVID-19 cases The two ways to get new drugs Develop novel antiviral drugs for SARS-CoV-2 Repurpose existing FDA -approved drugs to treat COVID-19 Ivermectin is the most studied “repurposed” medication globally, in randomized clinical trials, retrospective studies and meta- analyses. Molnupiravir and Ivermectin Anti-SARS- CoV-2 Mechanisms, Pharmacokinetics and Pharmacodynamics Molnupiravir is a broad spectrum antiviral agent against SARS- CoV-2, SARS-CoV, seasonal or pandemic influenza and MERS corona virus Ivermectin is an FDA-approved, WHO essential drug used as broad spectrum antiparasitic, antibiotic and which has demonstrated broad spectrum antiviral activity against RNA viruses, including HIV, Zika, MERS corona virus The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro https://www.sciencedirect.com/science/article/pii/S0166354220302011 5000-fold inhibition of SARS-CoV-2, (99.98% at 48 hours The inhibitory concentration IC50 of Molnupi…